Home / Research library / Mazdutide
Compound guide
Mazdutide: what the research covers
A dual agonist built on the oxyntomodulin scaffold, engaging the GLP-1 and glucagon receptors at once. The second target is the one that distinguishes it, and the one that complicates it.
What Mazdutide is
Oxyntomodulin is a naturally occurring gut peptide that activates both the GLP-1 and the glucagon receptor — a combination that looks contradictory, since glucagon raises blood glucose while GLP-1 lowers it. The resolution is that glucagon also increases energy expenditure and hepatic fat oxidation, and in the right ratio the GLP-1 arm offsets the glycaemic effect while the glucagon arm contributes additional energy expenditure.
Mazdutide is a synthetic analogue built on that scaffold, acylated for albumin binding and a long half-life. It is in clinical development, with trial data reported in obesity and type 2 diabetes.
The engineering question in this class is the ratio. Too much glucagon activity and glycaemic control suffers; too little and the compound is simply a GLP-1 agonist with extra complexity. The literature on dual agonists is largely a literature about getting that balance right.
Where it sits among the multi-agonists
Three architectures are worth distinguishing. A single GLP-1 receptor agonist acts on one incretin receptor. A dual GLP-1 and GIP agonist acts on two incretin receptors. Mazdutide, like survodutide, pairs GLP-1 with glucagon — a counter-regulatory hormone rather than a second incretin, which makes it mechanistically the more interesting and the less predictable of the two designs.
For a laboratory, the useful property is that mazdutide allows the glucagon receptor contribution to be probed in a molecule where the GLP-1 arm is present to offset it, which single-agent glucagon does not permit. Comparing a dual agonist against the two single agonists is the standard way to establish whether an effect requires both.
Research strands cover receptor selectivity and potency ratios at the two receptors, hepatic lipid metabolism, energy expenditure, and the pharmacology of albumin-bound acylated peptides.
How Amino Club supplies it
Supplied lyophilised in sealed vials as Mazdutide, released against the Certificate of Analysis for its own batch, as set out on the lab testing page.
This is an acylated peptide of substantial length, and it is handled accordingly: no vigorous agitation, small working volumes, cold storage of solutions and no repeated freeze-thaw cycling. The acyl chain means apparent solubility and aggregation behaviour are concentration dependent, which is worth establishing before a quantitative assay rather than during one. The sealed powder is stored below −18 °C. Diluents are under reconstitution supplies.
Related reading
Mazdutide belongs to the metabolic research peptides group with survodutide, cagrilintide, AOD-9604, 5-Amino-1MQ and AICAR.
Every guide is indexed in the research library. Certificates and storage are covered on the FAQ, quantity pricing through bulk and wholesale.
Research use only
Mazdutide supplied by Amino Club is a laboratory reference material. It is not a medicine, not a supplement, and not for human or veterinary use, and no dosing guidance or administration protocol is provided. The full terms are in the research use policy.